-

Curio Digital Therapeutics to Attend AHIP Annual Conference and Host Kiosk 

PRINCETON, N.J.--(BUSINESS WIRE)--Curio Digital Therapeutics, a leading provider of digital therapeutics, will be attending AHIP’s annual conference in Portland, Oregon from June 13th to the 15th and hosting a kiosk. The kiosk will showcase Curio’s innovative digital forward platforms, which are designed to help women manage their behavioral health during key reproductive phases.

“We are excited to be participating in AHIP’s annual conference,” said Shailja Dixit, Founder & CEO of Curio Digital Therapeutics. “This is a great opportunity for us to connect with health plans and share our vision to provide a digital forward solution for this vulnerable population. We believe that our platforms have the potential to revolutionize the way that women’s behavioral health is managed.”

Curio’s flagship product, MamaLiftTM, is a mobile application program intended to be used by women, as part of a healthy lifestyle, to help reduce their risk of depression and anxiety during pregnancy or after delivery. It features clinically validated screenings, neurobehavioral interventions, and elements of gamification. These digital elements are augmented by the Curio Care Network, which facilitates live health coaching and escalates patients to therapists as needed.

“We are committed to providing patients with the tools they need to manage their behavioral health,” said Shailja Dixit. “Our digital forward platforms are designed to be easy to use and are very engaging, and we believe that they can transform the trajectory of women’s behavioral health.”

Curio Digital Therapeutics is a privately held company headquartered in Princeton, New Jersey. The company was founded in 2019 by a team of experienced healthcare professionals and entrepreneurs.

About Curio Digital Therapeutics

Curio Digital is a pioneer in developing digital therapeutics solutions and interventions across the behavioral health continuum for women throughout the cycle of life. Curio aims to create a world where every woman can access a behavioral health solution at her fingertips. Curio is reshaping maternal mental health care by leveraging proprietary algorithms, clinically validated screening tools, and personalized digital behavioral interventions to facilitate timely identification and care. Curio’s products include MamaLift, focused on pregnancy and postpartum, FertiLift, an extension of fertility clinics providing behavioral health support, and Ferticalm, delivering support directly to patients during fertility treatments. For more information, visit Curio at www.curiodigitaltx.com.

Contacts

Robert Keough
Product Design and Marketing Manager
Curio Digital Therapeutics
RobertK@curiodigitaltx.com

Curio Digital Therapeutics


Release Versions

Contacts

Robert Keough
Product Design and Marketing Manager
Curio Digital Therapeutics
RobertK@curiodigitaltx.com

More News From Curio Digital Therapeutics

Cleveland Bakers and Teamsters Health and Welfare Fund Partners with Curio Digital Therapeutics to Revolutionize Maternal Mental Health Support for Members

CLEVELAND--(BUSINESS WIRE)--In a pioneering initiative aimed at prioritizing the mental well-being of its members, the Cleveland Bakers and Teamsters Health and Welfare Fund, a multi-employer trust fund, proudly announces an innovative partnership with Curio Digital Therapeutics, Inc. This collaboration will provide Participants and their spouses access to Curio's cutting-edge BellaLift™ platform, which offers a digital solution tailored to support mothers through pregnancy, motherhood, and pos...

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a complex mental health disorder affecting as many as one in seven women with a recent live birth experience.1 MamaLift Plus is a prescription‐only digital therapeutic intended to provide neurobehavioral interve...

Metro Nashville Public Schools Partner with Curio Digital Therapeutics to Provide Maternal Mental Health Support to Teachers-Nashville, TN

PRINCETON, N.J.--(BUSINESS WIRE)--Curio Digital Therapeutics, Inc., a leading provider of evidence-based digital solutions for female-focused mental health and wellness, is proud to announce a new partnership with the Metro Nashville Public Schools system (MNPS). MNPS is the school district that serves the city of Nashville, Tennessee, and Davidson County. The partnership will offer MNPS members access to Curio's MamaLiftTM program, a personalized and interactive digital solution that helps mot...
Back to Newsroom